Just conducted a kitchen lab experiment.
Anteo Tech's AnteoBind retails for $828 AUD on the Merck site for 10mls
In the kitchen, 2mls provided 200 drops from an eye droplet vessel.
Maths says 1000 drops can be extracted from a 10mls bottle
Let us assume that one droplet is required for each test kit as one droplet is not much liquid at all
Let us also assume that the wholesale price (ADO selling price) is $414 AUD as Merck retail is $828 AUD
Then ADO revenue component for each test kit could be around 41 cents if above assumptions stack up
ADO raw materials revenue for Dec 31st quarter was $235,800
Ellume max production capacity was 300,000 kits for the quarter
If all (100%) of ADO raw materials was used for Ellume order then sales value equates to 78c per kit (highly unlikely)
If 50% of ADO raw materials was used for Ellume order then sales value equates to 39c per kit (more likely)
Anyway, the revenue component to ADO for each sales kit is going to be significantly higer than the 1 to 5c espoused by others
- Forums
- ASX - By Stock
- ADO
- The Revenue numbers could be staggering
The Revenue numbers could be staggering, page-41
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $54.77M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.1¢ | $21.58K | 1.020M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 378168 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.021 |
10 | 1443457 | 0.020 |
10 | 2127381 | 0.019 |
5 | 1657002 | 0.018 |
4 | 1574748 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 378168 | 5 |
0.023 | 642868 | 9 |
0.024 | 141966 | 2 |
0.025 | 478846 | 7 |
0.026 | 83915 | 2 |
Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |